Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Growth factor pathways in proliferative glomerulonephritis.

A V Cybulsky1

  • 1Department of Medicine, McGill University Health Centre, Montreal, Quebec, Canada. acybul@po-box.mcgill.ca

Current Opinion in Nephrology and Hypertension
|June 10, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Complement C5b-9 induces cyclooxygenase-2 gene transcription in glomerular epithelial cells.

American journal of physiology. Renal physiology·2001
Same author

Cytosolic phospholipase A2-alpha associates with plasma membrane, endoplasmic reticulum and nuclear membrane in glomerular epithelial cells.

The Biochemical journal·2000
Same author

Complement C5b-9-mediated arachidonic acid metabolism in glomerular epithelial cells : role of cyclooxygenase-1 and -2.

The American journal of pathology·2000
Same author

Complement-induced phospholipase A2 activation in experimental membranous nephropathy.

Kidney international·2000
Same author

Cyclooxygenases-1 and 2 couple to cytosolic but not group IIA phospholipase A2 in COS-1 cells.

Prostaglandins & other lipid mediators·2000
Same author

Complement C5b-9 induces receptor tyrosine kinase transactivation in glomerular epithelial cells.

The American journal of pathology·1999
Same journal

Sex differences in renal acid-base regulation.

Current opinion in nephrology and hypertension·2026
Same journal

Primary prevention of chronic kidney disease in type 2 diabetes mellitus with sodium-glucose cotransporter 2 inhibitors.

Current opinion in nephrology and hypertension·2026
Same journal

Financial and policy challenges of delivering kidney replacement therapies in resource-limited settings.

Current opinion in nephrology and hypertension·2026
Same journal

The role of kir4.1/Kir5.1 in mediating the effect of angiotensin-II on Na-Cl-cotransporter.

Current opinion in nephrology and hypertension·2026
Same journal

Role of the calcium-sensing receptor in regulating calcium transport in the thick ascending limb.

Current opinion in nephrology and hypertension·2026
Same journal

Social determinants of chronic kidney disease: from association to clinical and population action.

Current opinion in nephrology and hypertension·2026
See all related articles

Growth factors drive kidney disease progression by promoting cell proliferation and extracellular matrix expansion in glomerulonephritis. Understanding these pathways offers new therapeutic targets for human kidney diseases.

Area of Science:

  • Nephrology
  • Cell Biology
  • Molecular Medicine

Background:

  • Mesangioproliferative and crescentic glomerulonephritides involve growth factor production, glomerular cell proliferation, and extracellular matrix expansion.
  • Recent research elucidates mechanisms of mesangial cell proliferation and extracellular matrix interaction.
  • Selective interruption of injury mediators is a focus of current studies.

Purpose of the Study:

  • To investigate the role of growth factors in glomerular diseases.
  • To explore mechanisms of mesangial cell proliferation and extracellular matrix expansion.
  • To identify potential therapeutic targets for human glomerulopathies.

Main Methods:

  • Analysis of mitogenic signaling pathways.
  • Investigation of cell cycle regulation in glomerular epithelial cells.

Related Experiment Videos

  • Review of recent studies on growth factor mediators.

    • Main Results:

    • Growth factors and glomerular cell proliferation are implicated in focal segmental glomerulosclerosis and membranous nephropathy.
    • Mechanisms of mesangial cell proliferation and extracellular matrix interaction are better understood.
    • Selective interruption of mediators of injury shows promise.

    Conclusions:

    • A deeper understanding of growth factor pathways is crucial for developing novel treatment strategies.
    • Targeting growth factor pathways may offer new therapeutic avenues for human glomerulopathies.
    • Further research into these pathways can improve patient outcomes.